We are a leading of aflibercept anyra 2mg injection, pre-filled syringe from Amravati, India.
₹ 24990 / Box Get Latest Price
| Strength (Dose per ml) | 40 mg/ml |
| Packaging Type | Pre-filled Syringe |
| Invoice Type | With GST Bill |
| Manufacturer | Zydus |
| Usage / Application | Wet AMD, Macular Edema, Diabetic Retinopathy |
| Form | Solution for Injection |
| Packaging Size | 1 Unit |
| Active Ingredient | Aflibercept |
| Storage Requirements | Refrigeration (2-8°C) |
Minimum order quantity: 5 Box
Anyra™ is the first aflibercept 2mg biosimilar developed in India and is launched under licence from Regeneron and Bayer.
Anyra™ is approved for the treatment of wet age-related macular degeneration, diabetic retinopathy, visual impairment due to macular oedema following retinal vein occulsion, diabetic macular oedema and myopic choroidal neovascularisation.
Zydus’ Indian developed and manufactured biosimilar portfolio includes more than 13 biosimilars and complex biologics.
K Agrawal (CEO)
Shreeji Healthcare
Amravati - 444601, Maharashtra, India
